Entera Bio shareholders approve authorized share increase at annual meeting

• Entera Bio held its 2026 annual shareholder meeting on July 14, 2026.
• Shareholders backed an amendment raising authorized ordinary shares to 350,000,000 from 140,010,000; the change took effect upon approval.
• They also adopted a one-time increase of 2,500,000 ordinary shares available under the 2018 Equity Incentive Plan amendment.
• Shareholders ratified Kesselman & Kesselman as independent auditor for the fiscal year ending Dec. 31, 2026.
• An advisory vote on named executive officer pay passed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entera Bio Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-003510), on July 16, 2026, and is solely responsible for the information contained therein.